🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Vaccines made from a person's peripheral stem cells may make the...
Status
Unknown
Location
Jonsson Comprehensive Cancer Center, UCLA
Start Date
2000-12
Trial ID
NCT00005992
Treatments Being Tested
This study will evaluate the safety and efficacy of a prostate cancer vacci...
Status
Unknown
Location
Beth Israel Deaconess Medical Center
Start Date
2019-02-28
Trial ID
NCT03579654
Treatments Being Tested
Provenge is an investigational product designed to activate a man's own ant...
Status
Completed
Location
South Orange County Urological
Start Date
2003-07
Trial ID
NCT00065442
Treatments Being Tested
The main purpose of this study was to determine whether ADT started before ...
Status
Completed
Location
Urology Center of Alabama
Start Date
2011-09
Trial ID
NCT01431391
Treatments Being Tested
Background: \- Enzalutamide is a well tolerated hormone therapy that is us...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2013-07-22
Trial ID
NCT01875250
Treatments Being Tested
This study study aims to elucidate the immune responses to a shared antigen...
Status
Completed
Location
Washington University School of Medicine
Start Date
2018-09-14
Trial ID
NCT03532217
Background: * Flutamide is an approved drug for prostate cancer that block...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2007-02-23
Trial ID
NCT00450463
Treatments Being Tested
This study will test the ability of an experimental vaccine to increase the...
Status
Completed
Location
National Cancer Institute (NCI), 9000 Rockville Pike
Start Date
2000-06-13
Trial ID
NCT00005916
This Phase 2 clinical trial is testing a new immunotherapy combination (N-8...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-12-15
Trial ID
NCT06765902
Background: " Adenocarcinoma of the prostate is the most common cancer dia...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2003-05-22
Trial ID
NCT00060528